Literature DB >> 14594883

Survival differences between heart failure in general practices and in hospitals.

O Wendelboe Nielsen1, J Hilden, T McDonagh, J Fischer Hansen.   

Abstract

OBJECTIVES: To compare the survival of patients thought to have heart failure in general practice (GP-HF) with that of patients with heart failure in hospital (hospital-HF), patients with heart disease but without heart failure (non-HF), and a control group without heart disease. DESIGN AND
SETTING: Cross sectional study from general practice with a prospective follow up from 5.3 to 7.4 years. PARTICIPANTS: 2157 community participants, 1999 of whom lived outside nursing homes, were selected because they were registered with four general practitioners at entry. Study participants were divided into the four groups after a review of general practice case notes, questionnaires, and interviews. MAIN OUTCOME MEASURES: Five year survival and multivariate predictors of all cause mortality.
RESULTS: Five year survival was 76% in the control group (n = 571, mean age at entry 74.1 years), 71% in non-HF patients (n = 218, 74.4 years), 61% in GP-HF patients (n = 67, 75.8 years), and 39% in hospital-HF patients (n = 33, 76.7 years). The median survival times were 6.8 years for GP-HF patients and 3.9 years for hospital-HF patients. Significant predictors of mortality in the multivariate Cox model of 1979 patients living outside nursing homes were hospital-HF (hazard ratio (HR) 2.1, p = 0.002), GP-HF (HR 1.7, p = 0.004), non-HF heart disease (HR 1.4, p = 0.03), previous myocardial infarction (HR 1.6, p = 0.04), no response to questionnaire (HR 2.0, p < 0.0001), higher age (for every 10 years, HR 2.4, p < 0.0001), and male sex (HR 2.1, p < 0.0001). Other factors such as atrial fibrillation, hypertension, and diabetes were not significant.
CONCLUSION: Heart failure in general practice is associated with a worse survival than that seen in the control group but is better than for patients who have been treated at least once for heart failure in a hospital.

Entities:  

Mesh:

Year:  2003        PMID: 14594883      PMCID: PMC1767949          DOI: 10.1136/heart.89.11.1298

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

1.  Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice.

Authors:  O W Nielsen; J Hilden; J F Hansen
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

2.  Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests.

Authors:  O W Nielsen; J F Hansen; J Hilden; C T Larsen; J Svanegaard
Journal:  BMJ       Date:  2000-01-22

3.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

Authors:  T A McDonagh; A D Cunningham; C E Morrison; J J McMurray; I Ford; J J Morton; H J Dargie
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

4.  Incidence and aetiology of heart failure; a population-based study.

Authors:  M R Cowie; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; V Suresh; G C Sutton
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

5.  The prognosis of heart failure in the general population: The Rotterdam Study.

Authors:  A Mosterd; B Cost; A W Hoes; M C de Bruijne; J W Deckers; A Hofman; D E Grobbee
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

6.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

7.  Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk.

Authors:  O W Nielsen; J Hilden; C T Larsen; J F Hansen
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

8.  Predictors of prognosis in patients with stable mild to moderate heart failure.

Authors:  P Bettencourt; A Ferreira; P Dias; J Pimenta; F Friões; L Martins; M Cerqueira-Gomes
Journal:  J Card Fail       Date:  2000-12       Impact factor: 5.712

9.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.

Authors:  M Davies; F Hobbs; R Davis; J Kenkre; A K Roalfe; R Hare; D Wosornu; R J Lancashire
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

10.  Heart failure in the general population of men--morbidity, risk factors and prognosis.

Authors:  L Wilhelmsen; A Rosengren; H Eriksson; G Lappas
Journal:  J Intern Med       Date:  2001-03       Impact factor: 8.989

View more
  1 in total

1.  Prognosis following a diagnosis of heart failure and the role of primary care: a review of the literature.

Authors:  Nicholas R Jones; Fd Richard Hobbs; Clare J Taylor
Journal:  BJGP Open       Date:  2017-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.